Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$5,863,000 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
3 quarters on record
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Jun 30, 2026CallValue
$34,572,000
CallShares
600,000
PutValue
$19,049,172
PutShares
330,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIADEMA PARTNERS LP holds $10,595,985 across 3 Drug Manufacturers - General names.
All Filings in BMY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,572,000 | 600,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $19,049,172 | 330,600 | Put | Sole | 2026-08-14 | |
| 2025-09-30 | $8,118,000 | 180,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $5,863,000 | 130,000 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $9,049,600 | 160,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||